Table of Content



1. Introduction 9
1.1 Study Scope 9
1.2 The Insight Partners Research Report Guidance 9
1.3 Market Segmentation
1.3.1 US Prostate Cancer Nuclear Medicine Diagnostics Market – By Type
1.3.2 US Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product

2. Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. US Prostate Cancer Nuclear Medicine Diagnostics Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion

5. US Prostate Cancer Nuclear Medicine Diagnostics Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Prostate Cancer
5.1.2 Growth Of Innovative Radiopharmaceuticals
5.2 Key Market Restraints
5.2.1 Strict Guidelines for Storage, Production, & Use of Radiopharmaceuticals
5.3 Key Market Opportunities
5.3.1 Rising Demand For Precise Diagnostic Methods
5.4 CURRENT TREND
5.4.1 Use of Hybrid Nuclear Medicine For Treatment
5.5 Impact analysis

6. Prostate Cancer Nuclear Medicine Diagnostics – US Market Analysis
6.1 US Prostate Cancer Nuclear Medicine Diagnostics Market Overview
6.2 Market Positioning of Key Players

7. US Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type
7.1 Overview
7.2 US Prostate Cancer Nuclear Medicine Diagnostics Market, By Type (2019 and 2027)
7.2.1.1 US Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2027 (USD Million)
7.3 SPECT
7.3.1 Overview
7.3.2 SPECT: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
7.4 PET
7.4.1 Overview
7.4.2 PET: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)

8. US Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product
8.1 Overview
8.2 US Prostate Cancer Nuclear Medicine Diagnostics Market, By Product (2019 and 2027)
8.2.1.1 US Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2027 (USD Million)
8.3 F-18
8.3.1 Overview
8.3.2 F-18: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
8.4 C-11
8.4.1 Overview
8.4.2 C-11: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
8.5 Ga68-PSMA
8.5.1 Overview
8.5.2 Ga68-PSMA: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)

9. US Prostate Cancer Nuclear Medicine Diagnostics Market Industry Landscape
9.1 Overview
9.2 Growth Strategies In The Prostate Cancer Nuclear Medicine Diagnostics Market, 2017-2020
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview

10. COMPANY PROFILES
10.1 Blue Earth Diagnostics Limited
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Progenics Pharmaceuticals, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Curium
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Telix Pharmaceuticals Ltd.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 NCM-USA LLC
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 ABX advanced biochemical compounds GmbH
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Jubilant Radiopharma
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Lantheus Medical Imaging, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Advanced Accelerator Applications (Novartis AG)
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Theragnostics
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments

11. Appendix
11.1 About The Insight Partners
11.2 Word Index



List of Figures


Figure 1. US Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation
Figure 2. US Prostate Cancer Nuclear Medicine Diagnostics Market Overview
Figure 3. PET is Expected to Show Remarkable Growth During Forecast Period
Figure 4. Ga68-PSMA is Expected to Have Fastest Growth During Forecast Period
Figure 5. Prostate Cancer Nuclear Medicine Diagnostics Market, Industry Landscape
Figure 6. US: PEST Analysis
Figure 7. Expert Opinion
Figure 8. US Prostate Cancer Nuclear Medicine Diagnostics Market – Impact Analysis of Drivers and Restraints
Figure 9. Overview of US Prostate Cancer Nuclear Medicine Diagnostics Market
Figure 10. Market Positioning Of Key Players In US Prostate Cancer Nuclear Medicine Diagnostics Market
Figure 11. US Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Share, by Type (2019 and 2027)
Figure 12. SPECT: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 13. PET: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 14. US Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Share, by Product (2019 and 2027)
Figure 15. F-18: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 16. C-11: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 17. Ga68-PSMA: US Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 18. Growth Strategies In The Prostate Cancer Nuclear Medicine Diagnostics Market, 2017-2020


List of Tables


Table 1. US Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. US Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2027 (USD Million)
Table 3. Recent Inorganic Growth Strategies In The Prostate Cancer Nuclear Medicine Diagnostics Market
Table 4. Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics market
Table 5. List of Abbreviation